|
1
|
Bianco P and Gehron Robey P: Marrow
stromal stem cells. J Clin Invest. 105:1663–1668. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parekkadan B and Milwid JM: Mesenchymal
stem cells as therapeutics. Annu Rev Biomed Eng. 12:87–117. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Philippe B, Luc S, Valérie PB, Jérôme R,
Alessandra BR and Louis C: Culture and use of mesenchymal stromal
cells in phase I and II clinical trials. Stem Cell Int.
503593:2010.
|
|
4
|
Meijer GJ, de Bruijn JD, Koole R and van
Blitterswijk CA: Cell-based bone tissue engineering. PLoS Med.
4:e92007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Griffin M, Iqbal SA and Bayat A: Exploring
the application of mesenchymal stem cells in bone repair and
regeneration. J Bone Joint Surg Br. 93:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohyeldin A, Garzón-Muvdi T and
Quiñones-Hinojosa A: Oxygen in stem cell biology: a critical
component of the stem cell niche. Cell Stem Cell. 7:150–161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Araldi E and Schipani E: Hypoxia, HIFs and
bone development. Bone. 47:190–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abdollahi H, Harris LJ, Zhang P, McIlhenny
S, Srinivas V, Tulenko T and DiMuzio PJ: The role of hypoxia in
stem cell differentiation and therapeutics. J Surg Res.
165:112–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salim A, Nacamuli RP, Morgan EF, et al:
Transient changes in oxygen tension inhibit osteogenic
differentiation and Runx2 expression in osteoblast. J Biol Chem.
279:40007–40016. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Coyle CH, Izzo NJ and Chu CR: Sustained
hypoxia enhances chondrocyte matrix synthesis. J Orthop Res.
27:793–799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivanovic Z: Hypoxia or in situ normoxia:
The stem cell paradigm. J Cell Phys. 219:271–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El Tamer MK and Reis RL: Progenitor and
stem cells for bone and cartilage regeneration. J Tissue Eng Regen
Med. 3:327–337. 2009.PubMed/NCBI
|
|
13
|
Gao YS and Zhang CQ: Cytotherapy of
osteonecrosis of the femoral head: a mini review. Int Orthop.
34:779–782. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma T, Grayson WL, Fröhlich M and
Vunjak-Novakovic G: Hypoxia and stem cell-based engineering of
mesenchymal tissues. Biotechnol Prog. 25:32–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mazumdar J, Dondeti V and Simon MC:
Hypoxia-inducible factors in stem cells and cancer. J Cell Mol Med.
13:4319–4328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holzwarth C, Vaegler M, Gieseke F, et al:
Low physiologic oxygen tensions reduce proliferation and
differentiation of human multipotent mesenchymal stromal cells. BMC
Cell Biol. 11:112010. View Article : Google Scholar
|
|
17
|
Potier E, Ferreira E, Andriamanalijaona R,
Pujol JP, Oudina K, Logeart-Avramoglou D and Petite H: Hypoxia
affects mesenchymal stromal cell osteogenic differentiation and
angiogenic factor expression. Bone. 40:1078–1087. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grayson WL, Zhao F, Bunnell B and Ma T:
Hypoxia enhances proliferation and tissue formation of human
mesenchymal stem cells. Biophys Biochem Res Commun. 358:948–953.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S, Zhou Y, Seavey CN, Singh AK, Xu X,
Hunt T, Hoyt RF Jr and Horvath KA: Rapid and dynamic alterations of
gene expression profiles of adult porcine bone marrow-derived stem
cell in response to hypoxia. Stem Cell Res. 4:117–128. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao YS, Ding H, Xie XT and Zhang CQ:
Osteogenic induction protects rat bone morrow-derived mesenchymal
stem cells against hypoxia-induced apoptosis in vitro. J Surg Res.
184:873–879. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hauzeur JP and Gangji V: Phases 1–3
clinical trials using adult stem cells in osteonecrosis and
nonunion fractures. Stem Cells Int. 2010:4101702010.
|
|
22
|
Bianco P, Riminucci M, Gronthos S and
Robey PG: Bone marrow stromal stem cells: nature, biology, and
potential applications. Stem Cells. 19:180–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khan M, Kwiatkowski P, Rivera BK and
Kuppusamy P: Oxygen and oxygenation in stem-cell therapy for
myocardial infarction. Life Sci. 87:269–274. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu W, Chen J, Cong X, Hu S and Chen X:
Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem
cells. Stem Cells. 24:416–425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Basciano L, Nemos C, Foliguet B, de Isla
N, de Carvalho M, Tran N and Dalloul A: Long term culture of
mesenchymal stem cells in hypoxia promotes a genetic program
maintaining their undifferentiated and multipotent status. BMC Cell
Biol. 12:122011. View Article : Google Scholar
|
|
26
|
Müller J, Benz K, Ahlers M, Gaissmaier C
and Mollenhauer J: Hypoxic conditions during expansion culture
prime human mesenchymal stromal precursor cells for chondrogenic
differentiation in three-dimensional cultures. Cell Transplant.
20:1589–1602. 2011.
|
|
27
|
Robins JC, Akeno N, Mukherjee A, et al:
Hypoxia induces chondrocyte-specific gene expression in mesenchymal
cells in association with transcriptional activation of Sox9. Bone.
37:313–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baumgartner L, Arnhold S, Brixius K,
Addicks K and Bloch W: Human mesenchymal stem cells: Influence of
oxygen pressure on proliferation and chondrogenic differentiation
in fibrin glue in vitro. J Biomed Mater Res A. 93:930–940.
2010.PubMed/NCBI
|
|
29
|
Yoshida Y, Takahashi K, Okita K, Ichisaka
T and Yamanaka S: Hypoxia enhances the generation of induced
pluripotent stem cells. Cell Stem Cell. 5:237–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Santilli G, Lamorte G, Carlessi L, Ferrari
D, Rota Nodari L, Binda E, Delia D, Vescovi AL and De Filippis L:
Mild hypoxia enhances proliferation and multipotency of human
neural stem cells. PLoS One. 5:e85752010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prado-Lopez S, Conesa A, Armiñán A,
Martínez-Losa M, Escobedo-Lucea C, Gandia C, et al: Hypoxia
promotes efficient differentiation of human embryonic stem cells to
functional endothelium. Stem Cells. 28:407–418. 2010.PubMed/NCBI
|
|
32
|
Volkmer E, Kallukalam BC, Maertz J, Otto
S, Drosse I, Polzer H, et al: Hypoxic preconditioning of human
mesenchymal stem cells overcomes hypoxia-induced inhibition of
osteogenic differentiation. Tissue Eng Part A. 16:153–164. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goda N, Ryan HE, Khadivi B, McNulty W,
Rickert RC and Johnson RS: Hypoxia-inducible factor 1 alpha is
essential for cell cycle arrest during hypoxia. Mol Cell Biol.
23:359–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tamama K, Kawasaki H, Kerpedjieva SS, Guan
J, Ganju RK and Sen CK: Differential roles of hypoxia inducible
factor subunits in multipotential stromal cells under hypoxic
condition. J Cell Biochem. 112:804–817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liras A: Future research and therapeutic
applications of human stem cells: general, regulatory, and
bioethical aspects. J Transl Med. 8:1312010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Raheja LF, Genetos DC, Wong A and
Yellowley CE: Hypoxic regulation of mesenchymal stem cell
migration: the role of RhoA and HIF-1α. Cell Biol Int. 35:981–989.
2011.PubMed/NCBI
|
|
37
|
Liu L and Rando TA: Manifestations and
mechanisms of stem cell aging. J Cell Biol. 193:257–266. 2011.
View Article : Google Scholar
|
